These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10541285)

  • 1. Zonal heterogeneity in action of angiotensin-converting enzyme inhibitor on renal microcirculation: role of intrarenal bradykinin.
    Matsuda H; Hayashi K; Arakawa K; Naitoh M; Kubota E; Honda M; Matsumoto A; Suzuki H; Yamamoto T; Kajiya F; Saruta T
    J Am Soc Nephrol; 1999 Nov; 10(11):2272-82. PubMed ID: 10541285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelium-derived hyperpolarizing factor in ACE inhibitor-induced renal vasodilation in vivo.
    Matsuda H; Hayashi K; Wakino S; Kubota E; Honda M; Tokuyama H; Takamatsu I; Tatematsu S; Saruta T
    Hypertension; 2004 Mar; 43(3):603-9. PubMed ID: 14769805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct modulation of superficial and juxtamedullary arterioles by prostaglandin in vivo.
    Matsuda H; Hayashi K; Arakawa K; Kubota E; Honda M; Tokuyama H; Suzuki H; Yamamoto T; Kajiya F; Saruta T
    Hypertens Res; 2002 Nov; 25(6):901-10. PubMed ID: 12484515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs.
    Kitakaze M; Minamino T; Node K; Komamura K; Shinozaki Y; Mori H; Kosaka H; Inoue M; Hori M; Kamada T
    Circulation; 1995 Aug; 92(4):950-61. PubMed ID: 7641379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.
    Mombouli JV; Illiano S; Nagao T; Scott-Burden T; Vanhoutte PM
    Circ Res; 1992 Jul; 71(1):137-44. PubMed ID: 1318793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses.
    Mombouli JV; Nephtali M; Vanhoutte PM
    Hypertension; 1991 Oct; 18(4 Suppl):II22-9. PubMed ID: 1916998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
    Matoba S; Tatsumi T; Keira N; Kawahara A; Akashi K; Kobara M; Asayama J; Nakagawa M
    Circulation; 1999 Feb; 99(6):817-22. PubMed ID: 9989969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium.
    Kitakaze M; Node K; Minamino T; Asanuma H; Ueda Y; Kosaka H; Kuzuya T; Hori M
    J Mol Cell Cardiol; 1998 Nov; 30(11):2461-6. PubMed ID: 9925380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of elevated renal angiotensin II in chronic renal ischemia.
    Tokuyama H; Hayashi K; Matsuda H; Kubota E; Honda M; Okubo K; Takamatsu I; Tatematsu S; Ozawa Y; Wakino S; Saruta T
    Hypertension; 2002 Jul; 40(1):34-40. PubMed ID: 12105135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
    Kitakaze M; Asanuma H; Funaya H; Node K; Takashima S; Sanada S; Asakura M; Ogita H; Kim J; Hori M
    J Am Coll Cardiol; 2002 Jul; 40(1):162-6. PubMed ID: 12103271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin.
    Imig JD; Falck JR; Wei S; Capdevila JH
    J Vasc Res; 2001; 38(3):247-55. PubMed ID: 11399897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury.
    Node K; Kitakaze M; Kosaka H; Minamino T; Mori H; Hori M
    Hypertension; 1998 Jun; 31(6):1290-8. PubMed ID: 9622144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
    Brouwers S; Smolders I; Massie A; Dupont AG
    Hypertension; 2013 Nov; 62(5):920-6. PubMed ID: 24041944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically increased angiotensin I-converting enzyme alters peripheral and renal vascular reactivity to angiotensin II and bradykinin in mice.
    Chollet C; Placier S; Chatziantoniou C; Hus-Citharel A; Caron N; Roussel R; Alhenc-Gelas F; Bouby N
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H350-H358. PubMed ID: 29101168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bradykinin on renal nerve stimulation-induced antidiuresis and norepinephrine overflow in anesthetized dogs.
    Tadano K; Yamasaki T; Matsumura Y
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):461-70. PubMed ID: 11300659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
    Fenoy FJ; Scicli G; Carretero O; Roman RJ
    Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition.
    Kon V; Fogo A; Ichikawa I
    Kidney Int; 1993 Sep; 44(3):545-50. PubMed ID: 8231026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution by bradykinin to the natriuretic response to the angiotensin converting enzyme inhibitor ramiprilat in spontaneously hypertensive rats.
    Sakamoto T; Chen C; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):84-9. PubMed ID: 7935859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.